# Cardiol Therapeutics Inc. (CRDL.TO) fundamentals

Data as of 2026-09-08. TSX, Canada. Sector: Healthcare / Pharmaceuticals. Price C$3.05, market value C$356 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Cardiol Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 14.7×**. The shares trade at 14.7× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -6.8%** (5-yr avg -25.3%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -189.2%**. Return on equity is negative because earnings are negative.
- **Return on assets: -143.2%**. Each dollar of assets produces -143.2% of profit.

## Growth
- **EPS growth (1 yr): 23.5%**. Earnings per share rose 23.5%.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.6×**. It would take 0.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 4.16** (quick 4.16). Current assets cover the next year's liabilities 4.16 times.
- **Altman Z-score: 34.40**. A Z-score of 34.40 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Cardiol Therapeutics Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (2 analysts). 2 analysts cover Cardiol Therapeutics Inc.; the consensus is strong_buy, with an average price target of C$6.00 (+97% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 99.3%** (YTD 132.8%, 3-mo 94.3%). The shares are up 99.3% over twelve months including dividends.
- **From 52-week high: -3.2%** (149.0% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 73**. An RSI of 73 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.13** (volatility 61%). Beta of 1.13 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CRDL.TO · Page: https://foliofundamentals.com/stocks/crdl.to

Not investment advice.